4.7 Review

GSK3: A possible link between beta amyloid peptide and tau protein

期刊

EXPERIMENTAL NEUROLOGY
卷 223, 期 2, 页码 322-325

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.expneurol.2009.09.011

关键词

Alzheimer disease; Beta-amyloid peptide; ApoE4; GSK3; Presenilin; Tau

资金

  1. Comunidad de Madrid (NEURODEGMODELS-CM)
  2. Spanish Comision Interministerial de Ciencia y Tecnologia
  3. CIBER on Neurodegeneration
  4. Fundacion Ramon Areces

向作者/读者索取更多资源

Tau is a neuronal microtubule-associated phosphoprotein that is highly phosphorylated by glycogen synthase kinase 3 (GSK3). Tau phosphorylation by GSK3 regulates tau binding to microtubules, tau degradation and tau aggregation. Tau phosphorylation is important in Alzheimer disease pathology and in other tauopathies. In Alzheimer disease, it has been proposed that the peptide beta amyloid promotes GSK3 activation, resulting in tau phosphorylation. In this work, we review the links between beta amyloid peptide, tau protein and GSK3 that occur in familial Alzheimer disease. We also discuss the possible links between GSK3 and sporadic Alzheimer disease. Finally, we include a brief review of the pathology of animal models overexpressing GSK3. (C) 2009 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据